Publication: 2994

Publication: 2994

Bortezomib maintenance (BM) or consolidation (BC) following aggressive immunochemotherapy and autologous stem cell transplant (ASCT) for untreated mantle cell lymphoma (MCL): 8-year follow-up of CALGB 50403 (Alliance)

URL

Google Scholar

Citation:: Blood vol 132 (suppl 1) 146

Meeting Instance:: ASH 2018
Year:: 2018
Type:: Abstract
Sub type:: Oral
Funding:: NCTN
Endpoint:: Primary
Analysis:: Long-Term-Followup
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No

Parents:: None
Children:: 3168

Program:: OGC
Primary Committee:: Lymphoma
Sec. Committees:

Pharmas:: Millennium
Grants:: U10CA180821, U10CA180882, U24CA196171

Corr. Author:
Authors:: Lawrence D. Kaplan Matthew Maurer Wendy Stock Noreen Fulton Nancy Bartlett Adam Pettinger John Byrd Kristie A. Blum Anne S. LaCasce Eric D. Hsi David Hurd Amy Ruppert John P. Leonard Bruce. D. Cheson

Networks:: CA824, CAPITAL, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-OH007, NC002, NY018, OH070

Study: CALGB-50403
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: